drugset / Trial / NCT00105495

Efficacy Study in Removing Excess Iron From the Heart

NCT00105495

Phase 4 Completed 60 enrolled ApoPharma
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether deferiprone has superior efficacy in removing excess iron from the heart when compared with deferoxamine.

Timeline

Start
2002-12
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Deferiprone Small molecule
Subject Deferoxamine Other / unclassified